Dr. Muni, a vitreoretinal surgeon, was most recently in the news as lead author on research published in JAMA identifying a high sensitivity C-reactive protein (hsCRP) that can be used to identify diabetics at highest risk for vision loss. As well as the above credentials, he has studied clinical epidemiology at Harvard and surgery at the University of South California.